From Our Partners

Friday, May 27, 2022

News on Pathogens and Preparedness

Global Biodefense

No Result

View All Result

No Result

View All Result

No Result

View All Result

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

by Global Biodefense Staff

Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

by Global Biodefense Staff

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

by Global Biodefense Staff

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

by Global Biodefense Staff

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

by Global Biodefense Staff

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

by Global Biodefense Staff

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

by Global Biodefense Staff

Load More

Headline News

Some PASC Patients May Experience Long-Lasting Airway Disease — Even if They Only Had Mild COVID-19

Some PASC Patients May Experience Long-Lasting Airway Disease — Even if They Only Had Mild COVID-19

by Global Biodefense Staff

Patients in this study with post-acute sequelae of COVID-19 (PASC), or 'Long Covid', experienced small airway disease independent of initial...

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats

by Global Biodefense Staff

The National Institutes of Health (NIH) Countermeasures Against Chemical Threats (CounterACT) program has announced intentions to open a funding solicitation...

Neurological Symptoms are Present in Roughly Two-Thirds of Hospitalized COVID-19 Patients

Neurological Symptoms are Present in Roughly Two-Thirds of Hospitalized COVID-19 Patients

by Global Biodefense Staff

Molecular imaging uncovers effects of COVID-19 on the brain Incidence of dementia, parkinsonism and psychiatric disorders within six months after...

U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

by Global Biodefense Staff

The Centers for Disease Control and Prevention (CDC) has announced the availability of cooperative agreement funds for this fiscal year...

Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization

Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization

by Global Biodefense Staff

Northwestern University faculty and spinoff company developed the new technology A new highly sensitive, easy-to-use test for COVID-19 that requires...

New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines

New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines

by Global Biodefense Staff

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand...

Load More

News Highlights

Biodefense Headlines – 4 May 2022

Biodefense Headlines – 4 May 2022

Biodefense Headlines – 5 April 2022

Biodefense Headlines – 29 March 2022

From Our Partners

Industry Newswire

Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization

Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate

On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland

ATCC Announces Awards from DTRA Supporting Global Health and Biodefense

Bruker Enables High-Throughput Multiplex HTS in Support of Drug Discovery

Select Agents

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

Ebola Virus Can ‘Hide Out’ in the Brain After Treatment and Cause Recurrent Infections

Emergency Response Missions for Recovered Chemical Warfare Material

CARA Microbiologists Safeguard Against Biological Threat Agents

Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate

Biosecurity + Biodefense Jobs

Chemical & Biological Technologies Program Manager

Supply Chain Distribution Coordinator (Medical)

Graduate Fellow Program – Public/Healthcare Policy

Executive Assistant – Health Readiness Programs

Animal Caretaker NIAID IRF

Epidemiologist – DTRA Technical Reachback

Contracts + Grants

NIH to Further Invest in Point-of-Care Technologies Research Network

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats

U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats

DHS S&T Commercialization Accelerator Program 2022 Call for Proposals

Emergency Response Missions for Recovered Chemical Warfare Material

ORISE Research Fellowship for Advancing CBRN Medical Countermeasures

COVID-19 Coronavirus

NIH to Further Invest in Point-of-Care Technologies Research Network

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Congenital Syphilis Continues a Decade-Long Surge Across the US

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

We’ll See More ‘Hybrids’ Like Omicron XE as COVID Continues to Evolve

Journal Watch

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis

Particles Carrying Viruses Likely Travel Farther Than Previously Thought

Bucknell Researchers Head to Uganda to Study African Bats’ Immune Response to Ebola Virus

Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

Troubling Trends in Physician Vaccine Confidence in the United States

Northwestern University Researchers Develop Nanoparticle Vaccine Platform

Antibody Shows Promise for Developing Hantavirus Treatment

Antimicrobial Resistance

Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis

MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Program

Long Term Care Outbreak Strike Teams, Increased Laboratory Capacity Part of $2.1 Billion CDC Effort to Enhance Infection Control

Is it a Bacterial or Viral Infection? Novel MeMed Rapid Test Receives FDA Clearance

New Tool in the AMR Fight: Synthetic RNA That Hugs Bad Bacterial RNA and Won’t Let Go

From Our Partners

© 2022 Stemar Media Group LLC

No Result

View All Result

© 2022 Stemar Media Group LLC